Health Equity

Unresolved Issues in the Psychedelics Community

State programs' equity, adverse event management, community tensions, integration with mental health system, microdosing, and indigenous community respect are key topics discussed in the video.

Rebecca Martinez, Jonathan Treem, Tracey Tee

PS2023 Health Equity Plant Medicine Policy and Advocacy Public Benefit

Remarks from the Executive Director of the Colorado Department of Regulatory Agencies (DORA)

Executive Director Patty Salazar discusses Colorado's Natural Medicine Health Act.

Patty Salazar, Joshua White

PS2023 Health Equity Integration Policy Psychedelic Assisted Therapy Public Benefit Research and Science

Building the next generation of psychedelic care clinics

Integration of psychedelic therapy into healthcare requires clinics to provide safe care. Planning infrastructure carefully, considering environmental factors, is crucial for successful delivery of psychedelic services.

Daniel Kelly, Gregory Kearns, Payton Nyquvest

PS2023 Health Equity Policy and Advocacy Psychedelic Assisted Therapy Public Benefit Research and Science

Achieving market access and reimbursement for psychedelic therapy

Panel experts discuss insurance coverage requirements for wide accessibility of psychedelic therapy, addressing what payors will need to support the treatments.

Elliot Marseille, Dan Grossman, Sherry Rais, Leslie Nylund

PS2023 Health Equity Policy and Advocacy Psychedelic Assisted Therapy Psychedelic Science Research Research and Science

Group sessions can make psychedelic treatment more accessible: Empirical evidence

Dr. Smith and Dr. Jones analyze the economic impact of drug pricing and care costs on the psychedelic market at PS2023.

PS2023 Harm Reduction Health Equity Policy and Advocacy Psychedelic Assisted Therapy Research and Science Therapy Ethics

Telemedicine models for supporting psychedelic therapy

Panel explores how telemedicine can enhance psychedelic therapy practice, discussing benefits and risks of virtual care in light of pandemic-induced regulatory changes and improved meeting tech.

Juan Pablo Cappello, Jonathan Sabbagh

PS2023 Depression Health Equity Policy and Advocacy Psychedelic Assisted Therapy PTSD Veterans

Healing Our Heroes: A Dinner Honoring Veterans and First Responders

Veterans, First Responders, and families supporting psychedelic medicine will be honored at the conference for their mental health challenges and the urgent need for better care and resources.

Itzel Barakat, Justin LaPree

PS2023 Ancestral Knowledge Health Equity Indigenous People Psychedelic Assisted Therapy Psychedelic Science Social Justice

Embedding Health Equity Principles into Psychedelic-Assisted Therapy and Education

Session explores health equity challenges and opportunities in mainstream psychedelic therapy, focusing on experiences of 3 women of color. Topics include overcoming inequity, cultural trauma, power dynamics, and ancestral healing.

Claudia Cuentas, Sara Reed, Deran Young

PS2023 Health Equity Psychedelic Assisted Therapy Psychedelic-AT Public Benefit Therapy Ethics

Creating access to psychedelic-assisted therapy

Dr. Smith and Dr. Jones explore the latest advancements in psychedelic research, focusing on therapeutic applications and potential benefits for mental health.

Jennifer Tippett, Ben Nemser, Heidi Allen

PS2023 Business Health Equity Policy and Advocacy Psychedelic Science Research Research and Science

Innovations in Global Healthcare and Lessons for Psychedelics

Elliot Cohen (Pillpack, Amazon) and Protik Basu (World Bank, UN, Helena) share insights on healthcare delivery, psychedelics industry, scaling challenges, and technology's role in patient care.

Andrew “Mo” Septimus, Protik Basu, Elliot Cohen